Trials / Completed
CompletedNCT05815459
Mobile Observation Of Depression
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 84 (actual)
- Sponsor
- Emteq Ltd · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- —
Summary
The primary aim of this project is to test if OCOsense glasses can function as a digital phenotyping tool derived from behavioural and physiological signals related to facial expression and motion recorded using the glasses.
Detailed description
Assessment of participants living with a DSM5 research diagnosis of Bipolar disorder or Major depressive disorder as well as healthy controls who will be recruited and characterised through precision phenotyping involving cross-sectional assessment of biobehavioural and physiological markers of the symptoms of depression. Correlations between objective (i.e., OCOsense glasses captured) and subjective (i.e., self-reported) symptoms of depression will be measured within as well as across diagnoses. The resulting biobehavioral clusters will form the building block of a digital phenotyping tool based upon the wider spectrum of non-verbal behaviours and physiology defined and affected by the phenotype of depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OCOsense | Volunteers wear OCOsense glasses continuously during testing to monitor biobehavioural responses to tasks |
Timeline
- Start date
- 2022-07-15
- Primary completion
- 2023-02-01
- Completion
- 2023-02-01
- First posted
- 2023-04-18
- Last updated
- 2023-05-09
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05815459. Inclusion in this directory is not an endorsement.